Gene therapy and cellular engineering have opened new possibilities for treating genetic disorders and enhancing tissue regeneration. This session will focus on innovative gene-editing technologies and cellular modification strategies used in regenerative medicine. Researchers will discuss advances in genome engineering, cellular reprogramming, and therapeutic gene delivery. Emerging applications in tissue repair and disease treatment will be highlighted.
Presentations will explore technologies such as CRISPR-Cas systems, viral and non-viral vectors, and engineered cell therapies. Participants will gain insights into approaches designed to improve cellular functionality and regenerative outcomes. Recent preclinical and clinical studies demonstrating therapeutic potential will also be discussed. Novel strategies for precision medicine applications will be emphasized.
The session will address ethical concerns, regulatory frameworks, and safety considerations associated with gene-based therapies. Experts will discuss current challenges and future opportunities in cellular engineering. Collaborative research initiatives and translational prospects will also be explored. This session aims to advance the integration of genetic technologies into regenerative medicine.